Peptide-Oligonucleotide Conjugates (POCs) Synthesis

Introduction: The immunogenicity of peptide-oligonucleotide conjugates is one of the most consequential development risks facing sponsors working with this rapidly […]

Introduction to Peptide-Oligonucleotide Conjugates Specification Setting Peptide-Oligonucleotide Conjugates Specification Setting is the systematic process of establishing scientifically justified physical, chemical,

Introduction: A receptor-targeted peptide oligonucleotide conjugate (POC) is an engineered biotherapeutic that links an antisense oligonucleotide (ASO) payload to a

Introduction to Regulatory Expectations for Peptide-Oligonucleotide Conjugates in IND Submissions The regulatory pathway for advancing Peptide-Oligonucleotide Conjugates (POCs) in Investigational

Introduction The successful clinical development and regulatory approval of hybrid biotherapeutics depend on advanced analytical strategies for the Structural Characterization

The development and clinical advancement of hybrid biotherapeutics relies heavily on specialized HPLC Purification Services for Peptide-Oligonucleotide Conjugates that can

Introduction: The convergence of peptide chemistry and oligonucleotide biology has produced one of the most promising — and analytically demanding

Introduction to Mass Spectrometry Characterization of Peptide-Oligonucleotide Conjugates Mass spectrometry characterization of peptide-oligonucleotide conjugates is a sophisticated, multi-dimensional analytical approach

Peptide-oligonucleotide conjugates (POCs) have emerged as an innovative class of chimeric therapeutics that integrate the exceptional sequence specificity of nucleic